iShares Global Healthcare ETF (NYSEARCA:IXJ) Sets New 1-Year High – Still a Buy?

iShares Global Healthcare ETF (NYSEARCA:IXJ)’s stock price reached a new 52-week high during trading on Friday . The stock traded as high as $99.48 and last traded at $98.0080, with a volume of 122 shares traded. The stock had previously closed at $98.09.

iShares Global Healthcare ETF Price Performance

The firm has a market capitalization of $4.39 billion, a price-to-earnings ratio of 21.58 and a beta of 0.64. The firm has a 50 day moving average price of $95.22 and a 200-day moving average price of $89.89.

Institutional Trading of iShares Global Healthcare ETF

Several hedge funds have recently added to or reduced their stakes in the company. LOM Asset Management Ltd acquired a new stake in shares of iShares Global Healthcare ETF in the 3rd quarter valued at $26,000. Hantz Financial Services Inc. purchased a new position in iShares Global Healthcare ETF in the second quarter valued at $31,000. Franklin Resources Inc. increased its holdings in iShares Global Healthcare ETF by 80.0% in the second quarter. Franklin Resources Inc. now owns 360 shares of the company’s stock valued at $31,000 after buying an additional 160 shares during the last quarter. Atlantic Union Bankshares Corp acquired a new stake in iShares Global Healthcare ETF in the second quarter valued at $39,000. Finally, Strengthening Families & Communities LLC purchased a new stake in iShares Global Healthcare ETF during the 3rd quarter worth about $40,000.

iShares Global Healthcare ETF Company Profile

iShares Global Healthcare ETF (the Fund), formerly iShares S&P Global Healthcare Sector Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the S&P Global 1200 Healthcare Sector Index (the Index). The Index measures the performance of companies that Standards & Poor’s Financial Services LLC (S&P) deems to be a part of the consumer staples sector of the economy. It is a subset of the S&P Global 1200 Index. Component companies include healthcare providers, biotechnology companies and manufacturers of medical supplies, advanced medical devices and pharmaceuticals.